Homepage
Ending AIDS Is Possible
On the Do One Better podcast, amfAR CEO Kyle Clifford explains how the organization’s funded research is moving closer to a scalable, affordable, and easy-to-administer HIV cure.
The Role of Killer T Cells in an HIV Cure Strategy
An amfAR-supported HIV cure study investigates the timing of HIV-specific CD8+ “killer” T cell responses and the suppression of HIV reservoirs.
Maria Davis: Living Out Loud with HIV
HIV advocate and music promoter Maria Davis talks about the importance of finding your voice, self-care, and sustaining AIDS research.
Explore more on Research, Policy and Advocacy, and TREAT Asia
Meet amfAR CEO Kyle Clifford
A diagnosis that changed his life. A mission that could change millions more. Meet amfAR’s CEO—and hear why the search for a cure for HIV is personal.
Research Grants
amfAR is a leading nonprofit advancing scientific discovery to improve global health, with a primary and enduring commitment to ending the HIV/AIDS epidemic. As a catalyst for breakthrough science, amfAR supports innovative research in HIV and other diseases where viruses and the immune system play a critical role. Since 1985, amfAR has raised more than $950 million and awarded in excess of 3,900 grants to scientists worldwide.
Research Grants Awarded
Request for Proposals: Target Grants
March 10, 2026 3:00PM EDT
Donate Now and Fuel Lifesaving Research
Your generous gift will advance amfAR’s cutting-edge HIV/AIDS research. Give now and show the world that a cure isn’t just possible—it’s within reach.